X0708 D/A LIVE 0001802249 SEN-JAM PHARMACEUTICAL INC. 223 WALL STREET, #130 HUNTINGTON NY NEW YORK 11743 201-400-8083 DELAWARE None SEN-JAM PHARMACEUTICAL LLC Corporation true Jacqueline Iversen 223 Wall Street #130 Huntington NY NEW YORK 11743 Executive Officer Ms. Iversen is the Secretary of the Issuer. James Iversen 223 Wall Street, # 130 Huntington NY NEW YORK 11743 Director Executive Officer Mr. Iversen is the Chief Executive Officer, President and Treasurer of the Issuer. He is also the sole Director of the Issuer. Pharmaceuticals Decline to Disclose 06c true 0001567619-23-006555 2023-04-22 true true true true true true Convertible Promissory Notes; Warrants to purchase shares of common stock; Shares of common stock. false 0 10000000 295000 9705000 The total amount sold and number of investors reflects sales to only residents of the United States. false 6 0 0 0 false SEN-JAM PHARMACEUTICAL INC. /s/ James Iversen James Iversen CEO 2024-07-23